About the ‘Silent Killer’ Series

The San Francisco Public Press examined recent efforts to step up diagnosis, vaccination and treatment for hepatitis B. Chronic hepatitis B affects an estimated 305,000 people in California, with the vast majority of cases affecting people in Asian American and Pacific Islander communities. Deep racial and cultural disparities in illness caused by the hepatitis B virus have persisted for decades. A cure is in trials, but those inequities, along with federal funding cuts, could hamper its rollout.



This reporting was supported with a California Health Equity Fellowship from the USC Annenberg Center for Health Journalism and a grant from the Pulitzer Center.

PART 1: Poorly Tracked Virus Is a ‘Silent Killer’ Affecting Asian Americans Most

PART 2: Stigma, Insufficient Screening Keep Hepatitis B in the Shadows

PART 3: Researchers Seek Hepatitis B Cure as Trump Slashes Health Agency Funding

------------

Hep B Free